(19)
(11) EP 4 041 286 A1

(12)

(43) Date of publication:
17.08.2022 Bulletin 2022/33

(21) Application number: 20819907.5

(22) Date of filing: 13.10.2020
(51) International Patent Classification (IPC): 
A61K 38/46(2006.01)
C07K 14/31(2006.01)
 A61P 31/04(2006.01)
C12N 1/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 31/04; A61K 38/46
(86) International application number:
PCT/PL2020/050075
(87) International publication number:
WO 2021/075988 (22.04.2021 Gazette 2021/16)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 13.10.2019 PL 43144519

(71) Applicant: Miedzynarodowy Instytut Biologii Molekularnej I Komorkowej
02-109 Warszawa (PL)

(72) Inventors:
  • SABALA, Izabela
    96-100 Skierniewice (PL)
  • JAGIELSKA, Elzbieta
    00-127 Warszawa (PL)
  • KUCZYNSKA, Beata
    00-034 Warszawa (PL)
  • AUGUSTYNIAK, Weronika
    08-330 Kosów Lacki (PL)
  • MITKOWSKI, Pawel
    05-120 Legionowo (PL)
  • WYSOCKA, Alicja
    01-592 Warszawa (PL)

(74) Representative: Grzelak, Anna 
Sigeon IP, sp z o. o. ul. Raclawicka 146 p. II
02-117 Warszawa
02-117 Warszawa (PL)

   


(54) RECOMBINANT POLYPEPTIDE FOR USE AS A MEDICINE, ANTISEPTIC AGENT, ANTIBACTERIAL AGENT, ANTI-INFLAMMATORY AGENT, COMPOSITIONS COMPRISING IT AND USES THEREOF